SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0650+0.2%12:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Howard Williams6/6/2013 1:31:08 PM
   of 13111
 
"scottmo.rm" got my attention on the Yahoo board a few minutes ago. I've almost quit reading and using that board since they reformatted it but this post is interesting. (expand the messages)

finance.yahoo.com

What a URL! Anyway, FWIW, here's what he had to say yesterday (Wednesday) morning .....

"While I was unable to make the breakfast meeting with the CFO this morning was able to get a FULL recap of it and other things. The takeaway is that we think that BTD (breakthrough therapy designation) has been submitted for and we should hear this month—this is basically the avenue to getting AA (accelerated approval) –STOCK WILL JUMP on release of this news.

Also there have been MANY meetings this week (yest,today, again Friday) at Pfizer’s office which we think involve some regional licensing agreements (china and/or india) and I think Peter flies to Japan this month as well. –this would be a nice sized upfront fee that would then remove any future dilution in terms of share issuance.
These licensing talks so far have all been with Pfizer related entities so you can read the tea leaves and assume that eventually (I think by end of this year) PVCT will be completely swallowed up by a Pfizer bid and the figure is going to be more than 15X current stock price."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext